Cargando…

COVIDMED – An early pandemic randomized clinical trial of losartan treatment for hospitalized COVID-19 patients

OBJECTIVES: To assess the efficacy and safety of losartan for COVID-19 patients. METHODS: COVIDMED was a double-blinded, placebo-controlled platform RCT. Enrollees were randomized to standard care plus hydroxychloroquine, lopinavir/ritonavir, losartan, or placebo. Hydroxychloroquine and lopinavir/ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freilich, Daniel, Victory, Jennifer, Jenkins, Paul, Gadomski, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296371/ https://www.ncbi.nlm.nih.gov/pubmed/35874909 http://dx.doi.org/10.1016/j.conctc.2022.100968

Ejemplares similares

Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis
por: Di Stefano, Leon, et al.
Publicado: (2023)

Tick magnets: The occupational risk of tick‐borne disease exposure in forestry workers in New York
por: Roome, Amanda, et al.
Publicado: (2022)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Efficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury: A Randomized Clinical Trial
por: Puskarich, Michael A., et al.
Publicado: (2022)

Randomized placebo‐controlled trial of losartan for pediatric NAFLD
por: Vos, Miriam B., et al.
Publicado: (2022)

A pilot clinical trial with losartan in Myhre syndrome
por: Cappuccio, Gerarda, et al.
Publicado: (2020)

A Randomized, Double-Blind Trial of Lisinopril and Losartan for the Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy
por: Allen, Hugh D., et al.
Publicado: (2013)

Effect of losartan on Doppler sonography indices in kidney transplant patients: A randomized clinical trial
por: Nouri-Majalan, Nader, et al.
Publicado: (2009)

Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
por: Meng, Chang, et al.
Publicado: (2023)

A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19
por: Puskarich, Michael A., et al.
Publicado: (2021)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Losartan improves clinical outcome in Camurati Engelmann Disease
por: Ayyavoo, Ahila, et al.
Publicado: (2013)

Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers
por: Brunner, Wendy M., et al.
Publicado: (2022)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Correction: A Randomized, Double-Blind Trial of Lisinopril and Losartan for the Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy
Publicado: (2015)

Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan
por: Citterio, Lorena, et al.
Publicado: (2021)

Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial
por: Castilla‐Ojo, Noelle, et al.
Publicado: (2023)

Effects of Losartan on expression of connexins at the early stage of atherosclerosis in rabbits
por: Ruan, Li-ming, et al.
Publicado: (2010)

Effects of spironolactone and losartan on the early neovascularization of acute myocardial infarction
por: LIU, YAN, et al.
Publicado: (2014)

Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial
por: van Andel, Mitzi M, et al.
Publicado: (2020)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial
por: Radonic, Teodora, et al.
Publicado: (2010)

Losartan for Preventing Aortic Root Dilatation in Patients with Marfan Syndrome: A Meta-Analysis of Randomized Trials
por: Elbadawi, Ayman, et al.
Publicado: (2019)

Efficacy of Losartan in the management of Post-Dialysis Euvolemic Hypertension (HELD-Trial): A Single-Blind Randomized Control Trial
por: Aftab, Raja Ahsan, et al.
Publicado: (2016)

Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia
por: Geriak, Matthew, et al.
Publicado: (2021)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease
por: Vos, Miriam B., et al.
Publicado: (2018)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
por: Keković, Goran, et al.
Publicado: (2012)

Camurati-Engelmann Disease with Good Treatment Response to Losartan
por: Abdulla, Mansoor Cherumkuzhiyil
Publicado: (2019)

Losartan Treatment Could Improve the Outcome of TBI Mice
por: Xiong, Jianhua, et al.
Publicado: (2020)

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
por: McPherson, Stuart, et al.
Publicado: (2017)

Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes
por: Weil, E. Jennifer, et al.
Publicado: (2013)

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
por: Ripley, Elizabeth, et al.
Publicado: (2010)

Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial
por: Scholtes, Rosalie A., et al.
Publicado: (2022)

Effects of losartan and atorvastatin on the development of early posttraumatic joint stiffness in a rat model
por: Baranowski, Andreas, et al.
Publicado: (2019)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

A case of losartan-induced severe hyponatremia
por: Das, Saibal, et al.
Publicado: (2015)

Losartan risk for female in cisplatin-induced nephrotoxicity
por: Nematbakhsh, Mehdi, et al.
Publicado: (2019)

Drug-Induced Liver Injury Due To Losartan
por: Diogo, Joana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nrvcd7jlehhvoeei9vu6l0i84b